This supplement is based on presentations from a satellite symposium conducted in conjunction
with the American Pharmacists Association’s 158th Annual Meeting & Exposition. This CE activity is
jointly sponsored by Postgraduate Institute for Medicine, Inc, and Global Directions in Medicine, Inc,
and supported by an educational grant from Novo Nordisk Inc.
Sitagliptin and saxagliptin offer improved glycemic control in the
management of type 2 diabetes.
Insulin analogs have provided superior alternatives to conventional
This type of insulin is five times more potent than standard U-100 and
is utilized in patients requiring high doses of insulin.